DMARDs
You have to accept whatever comes and the only important thing is that you meet it with courage and with the best that you have to give - Eleanor Roosevelt
image by: HWN
HWN Suggests
Current and Emerging DMARDs for the Treatment of Rheumatoid Arthritis
Rheumatoid arthritis (RA) is the most prevalent form of inflammatory arthritis. It is a profoundly serious and severe disease that if it goes untreated could have severe consequences to the joints and health of the patient who carries this diagnosis. The treatment of RA has dramatically changed since the year 2000, with the discovery of the TNFis, then other biologics, and finally the JAKi. All these new medications with or without methotrexate in combination, tight control and treat to target have produced a revolution in the outcome of this disease.
Featured
DMARDs & Immunosuppressives
Updates from the Rheumatologist.
Articles of Interest
Biologic DMARDs
Clinical trials have shown that biologic DMARDs reduce inflammation. They can slow or prevent disease progression. Biologic DMARDs may be used if methotrexate or other conventional DMARDs fail. They seem to be most effective when used in combination with methotrexate.
Competition Heats Up in Rheumatoid Arthritis and Other Autoimmune Conditions
With the wide variety of treatment options currently available and more in the pipeline, payers are faced with the challenge of identifying the most clinically and economically effective allocation of treatments for RA.
Disease-modifying anti-rheumatic drugs (DMARDs)
Disease-modifying anti-rheumatic drugs (DMARDs) act by altering the underlying disease rather than treating symptoms. They're not painkillers, but they'll reduce pain, swelling and stiffness over a period of weeks or months by slowing down the disease and its effects on the joints. There are two types: conventional DMARDs and biological therapies.
DMARDs Under Study for Secondary Prevention of Cardiovascular Events
Several important lines of population and large cohort research have shown that rheumatoid arthritis (RA) patients have a substantially higher risk for myocardial infarction and major cardiovascular events...Several studies have documented the protective and normalizing effects of chronic methotrexate and TNF inhibition in lowering these morbid and mortal outcomes.
RA Medications: Which NSAID and Analgesic is Best for RA?
NSAIDs are recommended and prescribed to rheumatoid arthritis patients early on and throughout the disease course. Early use of NSAIDs helps alleviate symptoms of pain and stiffness by reducing inflammation in patients. Often times, DMARDs take weeks or months to begin working and so patients choose NSAIDs in the meantime to alleviate pain and continue with their daily activities.
The Facts About JAK Inhibitors for Rheumatoid Arthritis
This new arthritis medication might ease your joint pain — but it can also come with some risks.
Traditional Disease-Modifying Anti-Rheumatic Drugs (DMARDs)
These drugs are called “disease-modifying” because they interrupt the processes that cause damage in RA. The use of DMARDs for the treatment of RA greatly changed and improved outcomes for people with RA.
Resources
StatPearls
Disease-modifying antirheumatic drugs (DMARDs) are a class of immunomodulatory agents indicated for the treatment of inflammatory arthritides such as rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis, as well as connective tissue diseases and select malignancies.
